rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
1998-8-4
|
pubmed:abstractText |
To describe a syndrome of peripheral lipodystrophy (fat wasting of the face, limbs and upper trunk), hyperlipidaemia and insulin resistance in patients receiving potent HIV protease inhibitor therapy.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0269-9370
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
7
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
F51-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9619798-Adult,
pubmed-meshheading:9619798-Anti-HIV Agents,
pubmed-meshheading:9619798-Body Composition,
pubmed-meshheading:9619798-Cross-Sectional Studies,
pubmed-meshheading:9619798-Diabetes Mellitus,
pubmed-meshheading:9619798-Female,
pubmed-meshheading:9619798-HIV Infections,
pubmed-meshheading:9619798-HIV Protease Inhibitors,
pubmed-meshheading:9619798-Humans,
pubmed-meshheading:9619798-Hyperlipidemias,
pubmed-meshheading:9619798-Indinavir,
pubmed-meshheading:9619798-Insulin Resistance,
pubmed-meshheading:9619798-Lipodystrophy,
pubmed-meshheading:9619798-Male,
pubmed-meshheading:9619798-Nelfinavir,
pubmed-meshheading:9619798-Risk Factors,
pubmed-meshheading:9619798-Ritonavir,
pubmed-meshheading:9619798-Saquinavir,
pubmed-meshheading:9619798-Syndrome
|
pubmed:year |
1998
|
pubmed:articleTitle |
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.
|
pubmed:affiliation |
HIV Medicine Unit and Centre for Immunology, St Vincent's Hospital, Sydney, Australia.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|